The effects of trimetaphan camsylate and sodium nitroprusside on the catecholamine response to cardiac surgery were compared in a randomised double blind study of twelve male patients undergoing elective myocardial revascularisation. The solutions were titrated to maintain a mean arterial pressure of 70-85 mm Hg before and after bypass and < 70mm Hg during bypass. The rise in plasma adrenaline during cardiopulmonary bypass in the sodium nitroprusside group was significantly greater than that in the trimetaphan camsylate group. There was a smaller rise in plasma noradrenaline in the sodium nitroprusside patients but this was significantly higher than in the patients receiving trimetaphan camsylate.
SUMMARY
The effects of trimetaphan camsylate and sodium nitroprusside on the catecholamine response to cardiac surgery were compared in a randomised double blind study of twelve male patients undergoing elective myocardial revascularisation. The solutions were titrated to maintain a mean arterial pressure of 70-85 mm Hg before and after bypass and < 70mm Hg during bypass. The rise in plasma adrenaline during cardiopulmonary bypass in the sodium nitroprusside group was significantly greater than that in the trimetaphan camsylate group. There was a smaller rise in plasma noradrenaline in the sodium nitroprusside patients but this was significantly higher than in the patients receiving trimetaphan camsylate.
Administration of trimetaphan camsylate provides a simple and effective way to reduce catecholamine release during cardiopulmonary bypass.
Cardiopulmonary bypass has been shown to be a potent stimulus to the release of catecholamines"2 and may be associated with a high systemic vascular resistance. 3 It is now standard practice to use vasodilators such as sodium nitroprusside46 or glyceryl trinitrate7 to ameliorate the haemodynamic consequences of cardiopulmonary bypass. Ganglion blocking agents prevent the release of catecholamines from sympathetic nerve terminals and the adrenal medulla. Previous work has shown that the use of a ganglion blocking agent to produce elective hypotension in hip replacement reduces the secretion of catecholamines associated with the surgical stimulation and with the reduction in arterial pressure.8
The Accepted for publication 25 February 1986 Patients and methods
PATIENTS
Twelve male patients (aged 36-64 years) undergoing elective coronary artery bypass grafting were studied. All had chronic stable angina and none had had a myocardial infarction within six months of the study. Eleven were taking a l,B selective ,B blocking drug which was discontinued on the evening before operation. The patients were randomly allocated into two groups which proved to be well matched; Table 1 One of the two groups of patients received sodium nitroprusside (50mg in 50 ml 5% dextrose) and the other trimetaphan camsylate (250mg in 50 ml 5% dextrose). Previous preliminary work showed that these solutions cause similar falls in blood pressure when delivered at the same infusion rate. Coded solutions were presented foil wrapped and were given when required as an infusion via a Vickers Medical Treonic IP5 syringe pump. The rate of the infusion was titrated to maintain a mean arterial pressure of 70-85mmHg before and after bypass and not greater than 70 mmHg during bypass. ues. Immediately after bypass the plasma adrenaline returned rapidly to concentrations not significantly different from those after median sternotomy (0 977 (0 459) nmol/1) and did not subsequently change.
OPERATION
In contrast there was only a small rise in the group given trimetaphan camsylate, reaching a peak value of 1-425 (0-742) nmol/l after 30 minutes on bypass.
Overall there was a highly significant difference between the two groups (p < 002).
NORADRENALINE (FIG.2)
Changes in plasma noradrenaline resembled those of adrenaline but were less pronounced. 
TEMPERATURE AND pH
In both groups the temperature was rapidly reduced to 27°C during cardiopulmonary bypass. The lowest pH of 7*39 (corrected for temperature) was reached after 50 minutes on bypass. There were no significant differences in the temperature or pH between the two groups at any stage.
Discussion
This study demonstrates a striking rise in catecholamine concentrations during cardiopulmonary bypass when sodium nitroprusside is used to control blood pressure. This confirms the findings of other workers in animals' 011 and man'2 13 since the advent of the radioenzymatic assay.9 Hitherto, analysis of catecholamines by fluorimetric methods led to diverse reports of changes during operation and cardiopulmonary bypass.14 15 The increase in plasma adrenaline concentration was several times higher than the simultaneous increase in plasma noradrenaline. This 
The cause of the rise in catecholamines remains unclear. Some workers have suggested that it is related to hypothermia or acidosis. Profound hypothermia may be associated with increases in catecholamines'0 17 but there is no consensus on the effects of temperature on catecholamine release during cardiopulmonary bypass.'8 In our study there was no difference in tekmperature or pH between the two groups and these factors cannot explain the lower response in the trimetaphan camsylate group. Ganglion blockade is likely to reduce the increases in adrenaline and noradrenaline in response to any physiological stimulus and hence the cause of the rise cannot be determined from this study.
The rise in catecholamine concentrations during cardiopulmonary bypass may be associated with a very high systemic vascular resistance. 3 Engleman et al failed to show a significant correlation between the two,2 but their study was complicated by the use of sodium nitroprusside which tends to have opposing effects on systemic vascular resistance and sympathetic drive. In our study the trimetaphan camsylate and sodium nitroprusside were titrated against mean arterial pressure. Since the flow rate of the pump was kept constant, the solutions were effectively titrated against the systemic vascular resistance and were administered only when this rose. The reduction of the catecholamine response when trimetaphan camyslate was used provides indirect evidence that the sympathetic drive is a major determinant of the high systemic vascular resistance during cardiopulmonary bypass. The high systemic vascular resistance may have adverse effects on tissue oxygen delivery and impair myocardial function immediately after bypass.9 20 Furthermore, perfusion of the heart on bypass via non-coronary collateral flow with blood containing high uncontrolled levels of catecholamines may further deplete the metabolic reserves of the arrested heart.2' Reperfusion of the ischaemic heart is a critical stage and the catecholamine concentrations at this time are extremely high. [22] [23] [24] This has led some workers to speculate that P adrenoceptor antagonists or calcium channel blockers might be useful in protecting the heart from damage. ' 30 The use of pulsatile flow also failed to suppress the excessive catecholamine release during cardiopulmonary bypass,1 31 although in one study some reduction in plasma concentrations after bypass was shown. 32 Our study demonstrates that blockade of the sympathetic response to cardiopulmonary bypass was effective when trimetaphan camsylate was used to control blood pressure. This provides the haemodynamic benefits of vasodilatation while reducing further harmful effects of the high sympathetic drive and circulating catecholaniines. 
